Securities code: 300534 securities abbreviation: Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) Announcement No.: 2022-007 Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534)
Correction announcement
Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) (hereinafter referred to as “the company”) was posted on cninfo.com on January 13, 2022（ http://www.cn.info.com.cn. ）The announcement on the change of company name and renewal of business license of the holding subsidiary was disclosed. After post verification, due to the negligence of the staff, some contents in the original disclosure report were incorrectly entered. The specific corrections are as follows:
Before correction:
” Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) holding subsidiary Lanzhou Sanyuan Pharmaceutical Co., Ltd. changed its original name” Lanzhou Sanyuan Pharmaceutical Co., Ltd. “to” Gansu Pharmaceutical Group Lanzhou Sanyuan Pharmaceutical Co., Ltd. “due to the needs of business development and in order to better carry out its work and enhance its brand influence, and recently completed the registration of change of company name and the amendment of articles of association, It has obtained the business license approved and renewed by Lanzhou Chengguan District market supervision and Administration Bureau.
1、 The specific information contained in the newly obtained business license of the company is as follows:
……
2. Name: Gansu Pharmaceutical Group Lanzhou Sanyuan Pharmaceutical Co., Ltd
……
2、 Documents for future reference
1. Business license of Gansu Pharmaceutical Group Lanzhou Sanyuan Pharmaceutical Co., Ltd.
2. Notice of change of domestic company. “
After correction:
” Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) holding subsidiary Lanzhou Sanyuan Pharmaceutical Co., Ltd. changed its original name” Lanzhou Sanyuan Pharmaceutical Co., Ltd. “to” Gansu Pharmaceutical Group Sanyuan Pharmaceutical Co., Ltd. “due to the needs of business development and in order to better carry out its work and enhance its brand influence, and recently completed the company name change registration and amendment of the articles of association, It has obtained the business license approved and renewed by Lanzhou Chengguan District market supervision and Administration Bureau.
1、 The specific information contained in the newly obtained business license of the company is as follows:
……
2. Name: Gansu Pharmaceutical Group Sanyuan Pharmaceutical Co., Ltd
……
2、 Documents for future reference
1. Business license of Gansu Pharmaceutical Group Sanyuan Pharmaceutical Co., Ltd.
2. Notice of change of domestic company. “
Except for the above corrections, other contents of the original announcement remain unchanged. See the announcement on changing the company name and renewing the business license of the holding subsidiary (after correction) disclosed by cninfo.com for the specific contents after correction. The Company Apologizes for the inconvenience caused to the majority of investors. In the future, the company will strictly strengthen the audit in the process of information disclosure.
It is hereby announced.
Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) board of directors January 12, 2022
